GeneDx Holdings Corp. (NASDAQ:WGSWW – Get Free Report) was the recipient of a significant decrease in short interest in the month of May. As of May 15th, there was short interest totaling 13,670 shares, a decrease of 40.8% from the April 30th total of 23,087 shares. Based on an average daily volume of 97,480 shares, the days-to-cover ratio is presently 0.1 days.
GeneDx Price Performance
NASDAQ:WGSWW opened at $0.01 on Tuesday. GeneDx has a fifty-two week low of $0.00 and a fifty-two week high of $0.13. The business has a 50 day moving average price of $0.01 and a 200-day moving average price of $0.02.
GeneDx Company Profile
GeneDx is a molecular diagnostics company specializing in high-complexity genetic testing for rare and ultra-rare inherited disorders. The company leverages next-generation sequencing (NGS) technologies, including whole exome sequencing, targeted gene panels, and chromosomal microarray analysis, to deliver comprehensive diagnostic insights. Its services are designed to support clinicians in identifying genetic mutations that underlie pediatric and adult conditions, guiding patient management, treatment decisions, and genetic counseling.
Founded in 2000 by Dr.
Recommended Stories
- Five stocks we like better than GeneDx
- Palantir’s Drone Tailwind Puts Its Defense AI Story Back in Focus for Investors
- Why 1 Little-Known ETF Is Riding the AI Chip Shortage
- Why These Three Big Buybacks Are Sending Very Different Signals to Investors
- Drone Stocks Soar As Pentagon Considers Funding, Including a Trump-Linked Name
Receive News & Ratings for GeneDx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GeneDx and related companies with MarketBeat.com's FREE daily email newsletter.
